Core Viewpoint - A class action lawsuit has been filed against Coupang, Inc. for alleged misleading statements regarding its cybersecurity, which resulted in significant investor losses during the specified class period [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired Coupang securities from May 7, 2025, to December 16, 2025 [1]. - Investors have until February 17, 2026, to seek appointment as lead plaintiff representatives [2]. - The complaint claims that inadequate cybersecurity allowed a former employee to access sensitive customer information undetected for nearly six months [3]. Group 2: Company Impact - Following the cybersecurity incident, Coupang's CEO resigned, indicating a significant leadership change in response to the crisis [3]. - The lawsuit highlights the potential financial repercussions for Coupang, as investors reportedly suffered significant losses due to the alleged cybersecurity failures [3]. Group 3: Law Firm Background - Berger Montague, the law firm representing the plaintiffs, is noted for its expertise in complex civil litigation and has recovered over $50 billion for clients over its 55-year history [4]. - The firm has a strong track record in various legal areas, including securities and consumer protection, which may bolster the case against Coupang [4].

Core Viewpoint - Newegg Commerce, Inc. is under investigation for possible securities fraud following the detention of its controlling shareholder and chairman, He Zhitao, which has led to a significant drop in the company's stock price [3]. Group 1: Investigation and Legal Actions - The Portnoy Law Firm has initiated an investigation into Newegg for potential securities fraud and may file a class action on behalf of investors [1]. - Investors are encouraged to contact the Portnoy Law Firm to discuss their legal rights and options for pursuing claims to recover losses [2]. Group 2: Impact on Stock Price - Following the announcement of He Zhitao's investigation and detention, Newegg's stock price fell by $9.79, or 17.7%, closing at $45.53 per share on January 21, 2026, resulting in financial harm to investors [3].

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC ("KSF†) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 23, 2026 to file lead plaintiff applications in a securities class action lawsuit against BellRing Brands, Inc. (NYSE: BRBR), if they purchased or otherwise acquired the Company's securities between November 19, 2024 and August 4, 2025, inclusive (the "Class Period†). This acti. ...

Core Viewpoint - The SLM Corporation, also known as Sallie Mae, is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company misrepresented its financial stability and the effectiveness of its loan programs during a specific period in 2025 [1][3]. Group 1: Class Action Details - Investors in SLM securities from July 25, 2025, to August 14, 2025, can seek to be appointed as lead plaintiff in the class action lawsuit by February 17, 2026 [1]. - The lawsuit, titled Zappia v. SLM Corporation, accuses SLM and its executives of making false statements and failing to disclose significant increases in early-stage delinquencies [1][3]. Group 2: Allegations and Impact - The lawsuit alleges that SLM overstated the effectiveness of its loss mitigation and loan modification programs, as well as the overall stability of its private education loan delinquency rates [3]. - A report from investment bank TD Cowen indicated that July 2025 delinquencies increased by 49 basis points month-over-month, contradicting SLM's CFO's claims of normal seasonal trends, leading to an approximate 8% drop in SLM's stock price following the report [4]. Group 3: Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who invested in SLM securities during the class period to seek appointment as lead plaintiff, representing the interests of the class [5]. - The lead plaintiff can choose a law firm to litigate the case, and participation as lead plaintiff does not affect an investor's ability to share in any potential recovery [5]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6]. - The firm has been recognized for its significant recoveries in securities class action cases, including the largest recovery in history of $7.2 billion in the Enron case [6].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation for allegedly misleading investors regarding its business operations and sales performance during the specified Class Period [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired Integer securities from July 25, 2024, to October 22, 2025 [1]. - Investors have until February 9, 2026, to seek appointment as lead plaintiff representatives [2]. Group 2: Allegations Against the Company - The complaint claims that Integer overstated its competitive positioning in the market [3]. - It alleges that the company experienced undisclosed deterioration in sales of its electrophysiology devices [3]. - The company mischaracterized the key drivers of its growth, leading to a significant stock price drop of $35.22 per share, a decline exceeding 32% in a single day following the announcement of reduced sales guidance [3].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1][3]. Company Overview - Integer Holdings Corporation specializes in designing and manufacturing cardiac rhythm management and cardiovascular products, including electrophysiology devices that diagnose and treat arrhythmias [4]. Allegations of Securities Fraud - The lawsuit claims that Integer misrepresented the demand and revenue for its electrophysiology products, which had reportedly fallen sharply, contradicting the company's public statements about sales growth and market position [4][5]. Stock Price Decline - On October 23, 2025, Integer revised its 2025 sales guidance down to between $1.840 billion and $1.854 billion, significantly below analysts' expectations. The company also projected a net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026. This announcement led to a stock price drop of $35.22 per share, or over 32%, from $109.11 to $73.89 [6].

Core Viewpoint - A class action lawsuit has been filed against BellRing Brands, Inc. and its senior executives for securities fraud following a significant drop in stock price attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is filed by Bleichmar Fonti & Auld LLP in the U.S. District Court for the Southern District of New York, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. - Investors have until March 23, 2026, to request to be appointed to lead the case [3]. Group 2: Company Background - BellRing Brands develops, markets, and sells "convenient nutrition" products, primarily known for its Premier Protein ready-to-drink protein shakes [4]. - The company previously claimed that its sales growth was due to increased consumer demand and various positive factors, while downplaying competitive pressures [4]. Group 3: Stock Performance and Impact - On May 6, 2025, BellRing's CFO indicated that several key retailers had reduced their inventory levels, leading to a projected low single-digit growth for Q3, resulting in a stock price drop of $14.88 per share, or 19% [5]. - Following the release of Q3 2025 financial results on August 4, 2025, and subsequent comments about increased competition, the stock price fell by $17.46 per share, nearly 33% [6][7].

New York, New York--(Newsfile Corp. - January 23, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-heal ...

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of Ohio, captioned Lingam v. Bath & Body Works, Inc., et al., No. 2:26-cv-00039 [3]. - Investors have until March 16, 2026, to request to be appointed to lead the case [3]. Group 2: Company Performance and Strategy - Bath & Body Works is a specialty retailer focusing on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry [4]. - The company claimed that customers were responding favorably to its innovation and that its strategy was driving topline growth through category adjacencies [5]. Group 3: Stock Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 financial results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53, leading to a stock drop of $2.18 per share, or 6.9% [6]. - Following the Q3 2025 financial results on November 20, 2025, which revealed that the strategy of pursuing adjacencies had not grown the customer base, the stock fell by $5.22 per share, or 24.8% [7].

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Blue Owl Capital Inc. (NYSE: OWL) between February 6, 2025 and November 16, 2025 (the " Class Period") of the important February 2, 2026 lead plaintiff deadline. So what: If you purchased Blue Owl securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To j ...